Loracarbef

• Antibiotics
• Anti-infective Agents
• ATC:J01DC08

• (-)-Carnitine
• (-)-L-Carnitin
• (S)-Carnitine
• 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium
• Carnitine
• Carnitor
• Karnitin
• L-carnitine
• Nicetile
• Vitamin BT

• No information avaliable

C₁₆H₁₆ClN₃O₄

http://www.rxlist.com/cgi/generic/loracarb.htm

Loracarbef MSDS

No information avaliable

349.769 g/mol

No information avaliable

No information avaliable

Solid

0.286

No information avaliable

Used to treat upper respiratory tract bacterial infections, chronic bronchitis, pneumonia, sinusitis, pharyntitis and tonsillitis, skin absceses, urinary tract infections and pyelonephritis caused by E. coli, S. pyogenes, S. aureus, S. saprphyticus, S. penumoniae, H. influenzae and M. catarrhalis.

Loracarbef is considered a second generation cephalosporin antibiotic. The advantages of cephalosporin antibiotics include a broad range of activity, a safe record in children with almost no dose-related toxicity, and the lack of need to monitor levels. Adverse reactions are rare and consist primarily of hypersensitivity reactions with urticaria, nonspecific rash, and pruritus. Loracarbef can be used to treat a large number of bacterial infections caused by gram-negative and gram-positive bacteria, including upper respiratory tract bacterial infections, chronic bronchitis, pneumonia, sinusitis, pharyntitis and tonsillitis, skin absceses, urinary tract infections and pyelonephritis caused by E. coli, S. pyogenes, S. aureus, S. saprphyticus, S. penumoniae, H. influenzae and M. catarrhalis.

Well absorbed with approximately 90% absorbed from the gastrointestinal tract after oral ingestion.

Adverse effects include diarrhea, nausea, stomach upset, vomiting, headache, dizziness, rash, bone marrow depression.

http://www.drugs.com/MTM/lomefloxacin.html

Many kinds of gram-negative and gram-positive eubacteria